Preferences Of The General Public For Reimbursement Criteria For Expensive Drugs- A Multi Criteria Decision Analysis For Rituximab And Bevacizumab

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1722
https://www.valueinhealthjournal.com/article/S1098-3015(17)32056-9/fulltext
Title : Preferences Of The General Public For Reimbursement Criteria For Expensive Drugs- A Multi Criteria Decision Analysis For Rituximab And Bevacizumab
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32056-9&doi=10.1016/j.jval.2017.08.1722
First page : A684
Section Title : Health Care Use & Policy Studies
Open access? : No
Section Order : 1555
Categories :
Tags :
Regions :
ViH Article Tags :